Medical Writing/Editorial Assistance Medical writing support was provided by Kate Silverthorne, PhD, a contract writer working on behalf of Apollo, OPEN Health Communications, and William Townley, MRes, of Apollo, OPEN Health Communications, and funded by Novo Nordisk, under the direction of the authors and in accordance with Good Publication Practice (GPP) guidelines (www.ismpp.org/gpp-2022)
Importantly, these medications are indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, not as standalone treatments
Wegovy (Semaglutide) Weight Loss Injector 2.4 mg/0.75 mL is a prescription medication that contains the active ingredient semaglutide. It is used for weight management in adults who have a body mass index (BMI) of 30 kg/m or greater, or who have at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol
Losing significant muscle can make you feel colder than usual